Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic effects of cimetidine: potential uses.

G M Mavligit1

  • 1Department of Clinical Immunology and Biologic Therapy, M.D. Anderson Hospital and Tumor Institute, Houston, Texas 77030.

Pharmacotherapy
|January 1, 1987
PubMed
Summary

Cimetidine, a histamine H2 receptor antagonist, modulates suppressor T cells and shows potential in cancer therapy and antiviral treatments. Further research is needed to confirm these preliminary findings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CA 125: a clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen.

American journal of clinical oncology·2000
Same author

Carcinoma of the stomach metastatic to the liver that progressed after hepatic arterial infusion of cisplatin plus 5-floxuridine, and then dramatically regressed after chemoembolization based on positive chromogranin staining.

American journal of clinical oncology·1999
Same author

Hepatic arterial infusion of recombinant platelet factor-4 suppresses metastases to the lungs from tumors implanted into the livers of rabbits.

Cancer·1995
Same author

Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine.

Cancer·1995
Same author

Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver.

Cancer·1993
Same author

Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases.

Cancer·1992

Area of Science:

  • Immunology
  • Pharmacology
  • Oncology

Background:

  • Suppressor T lymphocytes are crucial for immune regulation.
  • Histamine (H2) receptors are present on suppressor T cells.
  • Cimetidine, an H2 receptor antagonist, affects T cell function.

Purpose of the Study:

  • To explore the immunomodulatory effects of cimetidine.
  • To investigate cimetidine's potential as an antineoplastic agent.
  • To assess cimetidine's role in antiviral therapies.

Main Methods:

  • Studies involved examining the effects of cimetidine on cellular and humoral immune responses.
  • Preclinical studies evaluated cimetidine's antineoplastic effects in tumor-bearing animals.
  • Clinical investigations explored cimetidine's efficacy in cancer treatment and herpesvirus infections.

Main Results:

  • Cimetidine demonstrated an ability to diminish suppressor T cell activity.
  • Preliminary evidence suggests an antineoplastic effect and potential as an immune potentiator.
  • Cimetidine showed modest tumor response rates when used in cancer treatment.
  • The drug accelerated healing in herpesvirus infections.

Conclusions:

  • Cimetidine exhibits immunomodulatory properties with potential applications in oncology.
  • Preliminary findings suggest cimetidine may enhance immune responses against cancer.
  • Further investigation into cimetidine's antiviral properties is warranted.

Related Experiment Videos